Cluster analysis of indicators of liver functional and preoperative low branched-chain amino acid tyrosine ration indicate a high risk of early recurrence in analysis of 165 hepatocellular carcinoma patients after initial hepatectomy

Surgery

Volumn 150, Issue 2, 2011, Pages 250-262

  Nakamura, Yukio ^a   Mizuguchi, Toru ^a   Kawamoto, Masaki ^a   Meguro, Makoto ^a   Harada, Kohei ^a   Ota, Shigenori ^a   Hirata, Koichi ^a  

^a SAPPORO MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA FETOPROTEIN; ANTITHROMBIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BRANCHED CHAIN AMINO ACID; CHOLINESTERASE; COLLAGEN TYPE 4; DECARBOXYPROTHROMBIN; GAMMA GLUTAMYLTRANSFERASE; HYALURONIC ACID; PREALBUMIN; RETINOL BINDING PROTEIN; SCATTER FACTOR; TYROSINE;

ADULT; AGE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; AMINO ACID BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLEEDING; BLOOD LEVEL; BODY HEIGHT; BODY WEIGHT; CANCER CLASSIFICATION; CANCER INVASION; CANCER PATIENT; CANCER SIZE; CANCER SURGERY; CLUSTER ANALYSIS; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER FUNCTION; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; RECURRENCE RISK; RETROSPECTIVE STUDY; THROMBOCYTE COUNT;

AGED; AMINO ACIDS, BRANCHED-CHAIN; CARCINOMA, HEPATOCELLULAR; CLUSTER ANALYSIS; HEPATECTOMY; HEPATOCYTE GROWTH FACTOR; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX; TYROSINE;

EID: 79960910795     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2011.06.001     Document Type: Article

References (48)

1. M.B. Thomas, D. Jaffe, M.M. Choti, J. Belghiti, S. Curley, and Y. Fong Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting J Clin Oncol 28 2010 3994 4005
2. J.D. Yang, and L.R. Roberts Hepatocellular carcinoma: a global view Nat Rev Gastroenterol Hepatol 7 2010 448 458
3. A. Tan, F. Aucejo, and R. Kim Is there a role for adjuvant treatment after hepatic resection for hepatocellular carcinoma? Oncology 78 2010 161 171
4. T. Mizuguchi, T. Katsuramaki, T. Nobuoka, M. Kawamoto, H. Oshima, and H. Kawasaki Serum hyaluronate level for predicting subclinical liver dysfunction after hepatectomy World J Surg 28 2004 971 976 (Pubitemid 40109879)
5. T. Mizuguchi, M. Nagayama, M. Meguro, T. Shibata, S. Kaji, and T. Nobuoka Prognostic impact of surgical complications and preoperative serum hepatocyte growth factor in hepatocellular carcinoma patients after initial hepatectomy J Gastrointest Surg 13 2009 325 333
6. F. Manizate, S.P. Hiotis, D. Labow, S. Roayaie, and M. Schwartz Liver functional reserve estimation: state of the art and relevance for local treatments: the Western perspective J Hepatobiliary Pancreat Sci 17 2010 385 388
7. I. Frades, and R. Matthiesen Overview on techniques in cluster analysis Methods Mol Biol 593 2010 81 107
8. J.S. Lee, J. Heo, L. Libbrecht, I.S. Chu, P. Kaposi-Novak, and D.F. Calvisi A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells Nat Med 12 2006 410 416
9. T. Li, B. Wan, J. Huang, and X. Zhang Comparison of gene expression in hepatocellular carcinoma, liver development, and liver regeneration Mol Genet Genomics 283 2010 485 492
10. N.P. Lee, K.W. Leung, N. Cheung, B.Y. Lam, M.Z. Xu, and P.C. Sham Comparative proteomic analysis of mouse livers from embryo to adult reveals an association with progression of hepatocellular carcinoma Proteomics 8 2008 2136 2149 (Pubitemid 351775792)
11. P.D. Schneider Preoperative assessment of liver function Surg Clin North Am 84 2004 355 373 (Pubitemid 38388272)
12. S.G. Sakka Assessing liver function Curr Opin Crit Care 13 2007 207 214 (Pubitemid 46328337)
13. D. Ribero, S.A. Curley, H. Imamura, D.C. Madoff, D.M. Nagorney, and K.K. Ng Selection for resection of hepatocellular carcinoma and surgical strategy: indications for resection, evaluation of liver function, portal vein embolization, and resection Ann Surg Oncol 15 2008 986 992
14. H. Moriwaki, Y. Miwa, M. Tajika, M. Kato, H. Fukushima, and M. Shiraki Branched-chain amino acids as a protein- and energy-source in liver cirrhosis Biochem Biophys Res Commun 313 2004 405 409 (Pubitemid 37543600)
15. J.E. Fischer, H.M. Rosen, A.M. Ebeid, J.H. James, J.M. Keane, and P.B. Soeters The effect of normalization of plasma amino acids on hepatic encephalopathy in man Surgery 80 1976 77 91
16. Y. Azuma, M. Maekawa, Y. Kuwabara, T. Nakajima, K. Taniguchi, and T. Kanno Determination of branched-chain amino acids and tyrosine in serum of patients with various hepatic diseases, and its clinical usefulness Clin Chem 35 1989 1399 1403 (Pubitemid 19187834)
17. H. Shimizu, K. Taniguchi, M. Sugiyama, and T. Kanno Rapid enzymatic analysis of plasma for tyrosine Clin Chem 36 1990 32 35
18. J.M. Argiles, and F.J. Lopez-Soriano The oxidation of leucine in tumour-bearing rats Biochem J 268 1990 241 244 (Pubitemid 20166678)
19. H.A. Choudry, M. Pan, A.M. Karinch, and W.W. Souba Branched-chain amino acid-enriched nutritional support in surgical and cancer patients J Nutr 136 2006 S314 S318
20. V.E. Baracos, and M.L. Mackenzie Investigations of branched-chain amino acids and their metabolites in animal models of cancer J Nutr 136 2006 S237 S242
21. K. Breuhahn, T. Longerich, and P. Schirmacher Dysregulation of growth factor signaling in human hepatocellular carcinoma Oncogene 25 2006 3787 3800 (Pubitemid 43980474)
22. G. Shiota, J. Okano, H. Kawasaki, T. Kawamoto, and T. Nakamura Serum hepatocyte growth factor levels in liver diseases: clinical implications Hepatology 21 1995 106 112
23. H. Yamagamim, M. Moriyama, H. Matsumura, H. Aoki, T. Shimizu, and T. Saito Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases Cancer 95 2002 824 834 (Pubitemid 34839675)
24. D. Dindo, N. Demartines, and P.A. Clavien Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 2004 205 213 (Pubitemid 38963009)
25. J.M. Llovet, C. Bru, and J. Bruix Prognosis of hepatocellular carcinoma: the BCLC staging classification Semin Liver Dis 19 1999 329 338
26. H. Imamura, K. Sano, Y. Sugawara, N. Kokudo, and M. Makuuchi Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test J Hepatobiliary Pancreat Surg 12 2005 16 22 (Pubitemid 40378835)
27. N. Kokudo, D.R. Vera, and M. Makuuchi Clinical application of TcGSA Nucl Med Biol 30 2003 845 849 (Pubitemid 38040993)
28. T. Katsuramaki, K. Fujimori, T. Furuhata, Y. Kimura, M. Meguro, and M. Nagayama Preoperative estimation of risk in hepatectomy using technetium-99m-galactosyl human serum albumin receptor amount by nonlinear 3-compartment model Hepatogastroenterology 50 2003 174 177 (Pubitemid 36182962)
29. T.M. Pawlik, R.T. Poon, E.K. Abdalla, I. Ikai, D.M. Nagorney, and J. Belghiti Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study Surgery 137 2005 403 410 (Pubitemid 40432037)
30. S.A. Shah, S.P. Cleary, A.C. Wei, I. Yang, B.R. Taylor, and A.W. Hemming Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes Surgery 141 2007 330 339 (Pubitemid 46371307)
31. C. Verslype, E. Van Cutsem, M. Dicato, N. Arber, J.D. Berlin, and D. Cunningham The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008 Ann Oncol 20 Suppl 7 2009 vii1 vii6
32. D. Poon, B.O. Anderson, L.T. Chen, K. Tanaka, W.Y. Lau, and E. Van Cutsem Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009 Lancet Oncol 10 2009 1111 1118
33. T. Suehiro, T. Matsumata, H. Itasaka, A. Taketomi, K. Yamamoto, and K. Sugimachi Des-gamma-carboxy prothrombin and proliferative activity of hepatocellular carcinoma Surgery 117 1995 682 691
34. B.I. Carr, F. Kanke, M. Wise, and S. Satomura Clinical evaluation of lens culinaris agglutinin-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin in histologically proven hepatocellular carcinoma in the United States Dig Dis Sci 52 2007 776 782
35. B.J. McMahon The natural history of chronic hepatitis B virus infection Hepatology 49 2009 S45 S55
36. A. Sangiovanni, G.M. Prati, P. Fasani, G. Ronchi, R. Romeo, and M. Manini The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients Hepatology 43 2006 1303 1310 (Pubitemid 43980109)
37. G. Malaguarnera, M. Giordano, I. Paladina, M. Berretta, A. Cappellani, and M. Malaguarnera Serum markers of hepatocellular carcinoma Dig Dis Sci 55 2010 2744 2755
38. D. Dahiya, T.J. Wu, C.F. Lee, K.M. Chan, W.C. Lee, and M.F. Chen Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience Surgery 147 2011 676 685
39. T. Kobayashi, T. Itamoto, H. Tashiro, H. Amano, A. Oshita, and Y. Tanimoto Tumor-related factors do not influence the prognosis of solitary hepatocellular carcinoma after partial hepatectomy J Hepatobiliary Pancreat Sci 2011
40. M. Minagawa, I. Ikai, Y. Matsuyama, Y. Yamaoka, and M. Makuuchi Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan Ann Surg 245 2007 909 922 (Pubitemid 46809293)
41. N.N. Rahbari, A. Mehrabi, N.M. Mollberg, S.A. Muller, M. Koch, and M.W. Buchler Hepatocellular carcinoma: current management and perspectives for the future Ann Surg 253 2011 453 469
42. M. Charlton Branched-chain amino acid enriched supplements as therapy for liver disease J Nutr 136 2006 S295 S298
43. A. McGhee, J.M. Henderson, W.J. Millikan Jr., J.C. Bleier, R. Vogel, and M. Kassouny Comparison of the effects of Hepatic-Aid and a Casein modular diet on encephalopathy, plasma amino acids, and nitrogen balance in cirrhotic patients Ann Surg 197 1983 288 293 (Pubitemid 13159266)
44. H. Michel, P. Bories, J.P. Aubin, G. Pomier-Layrargues, P. Bauret, and H. Bellet-Herman Treatment of acute hepatic encephalopathy in cirrhotics with a branched-chain amino acids enriched versus a conventional amino acids mixture. A controlled study of 70 patients Liver 5 1985 282 289 (Pubitemid 16203415)
45. H. Vilstrup, C. Gluud, F. Hardt, M. Kristensen, O. Kohler, and B. Melgaard Branched chain enriched amino acid versus glucose treatment of hepatic encephalopathy. A double-blind study of 65 patients with cirrhosis J Hepatol 10 1990 291 296 (Pubitemid 20162735)
46. F.B. Cerra, M. McMillen, R. Angelico, B. Cline, J. Lyons, and L. Faulkenbach Cirrhosis, encephalopathy, and improved results with metabolic support Surgery 94 1983 612 619 (Pubitemid 13012183)
47. E.H. Egberts, H. Schomerus, W. Hamster, and P. Jurgens Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double-blind placebo-controlled crossover study Gastroenterology 88 1985 887 895 (Pubitemid 15105878)
48. G. Marchesini, F.S. Dioguardi, G.P. Bianchi, M. Zoli, G. Bellati, and L. Roffi Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group J Hepatol 11 1990 92 101 (Pubitemid 20250834)